According to CECMED, such an agreement will make it possible to take advantage of friendship and cooperation from both companies, creating an even stronger framework for technical assistance at regulatory level.

Likewise, it will pave the way to new spaces for greater information and knowledge exchange to expand and strengthen collaboration between both companies in order to allow timely access to quality, safe and effective medicines.

During the event, CECMED Director Olga Lidia Jacobo reviewed the results of his center during over 30 years of foundation, as well as its actions to fight the Covid-19 pandemic.

Ms. Jacobo laid stress on CECMED’s willingness to cooperate with ANPP to exchange experiences acquired amid Covid-19, favoring a scenario of reciprocity and regulatory coordination between both countries.

mh/pll/mgt/cdg